233 related articles for article (PubMed ID: 11788896)
1. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
[TBL] [Abstract][Full Text] [Related]
3. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM; Staatz G; Alzen G; Andreopoulos D
Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
5. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
6. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.
Gwak HK; Kim WC; Kim HJ; Park JH
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):194-8. PubMed ID: 19910130
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
Matsumoto S; Kiyosue H; Komatsu E; Wakisaka M; Tomonari K; Hori Y; Matsumoto A; Mori H
Cancer; 2004 Jun; 100(11):2422-9. PubMed ID: 15160347
[TBL] [Abstract][Full Text] [Related]
9. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
[TBL] [Abstract][Full Text] [Related]
10. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment in unresectable extrahepatic biliary carcinoma.
Morganti AG; Trodella L; Valentini V; Montemaggi P; Costamagna G; Smaniotto D; Luzi S; Ziccarelli P; Macchia G; Perri V; Mutignani M; Cellini N
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):913-9. PubMed ID: 10705013
[TBL] [Abstract][Full Text] [Related]
12. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
[TBL] [Abstract][Full Text] [Related]
13. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274
[TBL] [Abstract][Full Text] [Related]
14. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
15. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
17. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
18. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
19. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
20. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
